-
Cash and cash equivalent 560 cr, debt 780 cr. Net debt 210 cr
-
Net debt: equity 0.11. Sufficient room to fund expansion through borrowing and internal accruals
-
YTD capital outlay 680cr, in Q4 we will spend 320 cr
-
Soft launch of Athma SaaS designed for small healthcare facilities such as diagnostic labs, nursing homes and standalone hospitals
This segment offers an underserved segment of the market scattered across tier 2/3 cities. -
1000 customers for subscription service in Banglore
-
EBITDA for new centres -7.3%. Mumbai Hospital has almost broken even.
-
Gurugram and Dharamshala are there in term of higher EBITA margin of 17%. Mumbai broke even in January, so it will take around a year to move to a higher margin of 17%
-
Doing 2000 cr Capex in Fy23/24. Once the capex is complete, it will take around two years to break even on the EBITA level. This will be a little faster as not all capex in greenfield
-The larger hospital can be tweaked to improve output. However, smaller hospitals do not have a leeway to improve once they reach maturity. -
ARPOB improvement will not happen through price increases but due to payor mix or handling complex patients or bringing inefficiencies
-
New faculty bought in Banglore has integrated well (Sparsh). Generated 30% EBITDA this quarter
Cayman
- Zero tax location for everyone, and it is not time bound
- Exploring opportunities in surrounding islands near Cayman
- New department for Rediology will be ready to treat payment from April 23 onwards.
-Only radiotherapy centre there - Patients from nearby islands are not yet contributed significantly.
- Average Revenue per person is increasing
- Increase in complexity of patients we treat, and it is likely to increase going forward with new oncology centres
- Doing 2000 cr Capex in Fy23/24. Once the capex is complete, it will take around 2 years to break even on the EBITA level. This will be a little faster as not all capex in greenfield
- New Capex is a separate location
- We offer an increasing number of services from the facility. That is a growth lever as well. For example, bought a high-volume ENT specialist earlier.
| Subscribe To Our Free Newsletter |
